Cerebrolysin is a peptide preparation derived from porcine brain proteins containing low-molecular-weight peptides and amino acids, investigated for neuroprotection, neuroplasticity, and neuroregeneration research.
| Purity | >98% |
| Form | Lyophilized powder |
| Storage | -20°C |
Science-backed research overview for this compound
Cerebrolysin is a preparation of enzymatically treated porcine brain-derived peptides under 10 kDa that cross the blood-brain barrier. It mimics the action of BDNF, NGF, GDNF, and CNTF, and has been studied in over 200 clinical trials for stroke recovery, TBI, and neurodegenerative conditions.
Cerebrolysin activates PI3K/Akt, MAPK/ERK, and JAK/STAT pathways, upregulates BDNF expression and TrkB receptor activation, reduces excitotoxicity and calpain-mediated neuronal death, and promotes hippocampal neurogenesis and cortical synaptogenesis.